These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31919007)

  • 21. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
    Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
    Raisch DW; Fudala PJ; Saxon AJ; Walsh R; Casadonte P; Ling W; Johnson BA; Malkerneker U; Ordorica P; Williford WO; Sather MR
    J Am Pharm Assoc (2003); 2005; 45(1):23-32. PubMed ID: 15730114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.
    Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L
    Addiction; 2016 Dec; 111(12):2177-2186. PubMed ID: 27367125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
    Irwin AN; Gray M; Ventricelli D; Boggis JS; Bratberg J; Floyd AS; Silcox J; Hartung DM; Green TC
    Res Social Adm Pharm; 2024 May; 20(5):512-519. PubMed ID: 38395644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels S; Novak S
    Res Social Adm Pharm; 2014; 10(2):285-96. PubMed ID: 23816495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
    Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
    Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Educating Pharmacists on a Prescription Drug Monitoring Program.
    Fleming ML; Phan Y; Ferries EA; Hatfield MD
    J Pharm Pract; 2016 Dec; 29(6):543-548. PubMed ID: 25947949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of an interactive workshop on community pharmacists' beliefs toward patient care.
    Guirguis LM; Lee S; Sanghera R
    Int J Clin Pharm; 2012 Jun; 34(3):460-7. PubMed ID: 22527476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior.
    Gavaza P; Fleming M; Barner JC
    Res Social Adm Pharm; 2014; 10(2):448-58. PubMed ID: 23953982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists' comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy.
    Lio I; Remines J; Nadpara PA; Goode JKR
    J Am Pharm Assoc (2003); 2018; 58(4S):S89-S93. PubMed ID: 30006191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparing student pharmacists to identify opioid misuse, prevent overdose and prescribe naloxone.
    Skoy E; Eukel H; Frenzel J; Werremeyer A
    Curr Pharm Teach Learn; 2019 May; 11(5):522-527. PubMed ID: 31171255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a Multicomponent Educational Intervention on Community Pharmacy-Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial.
    Hohmann LA; Fox BI; Garza KB; Wang CH; Correia C; Curran GM; Westrick SC
    Ann Pharmacother; 2023 Jun; 57(6):677-695. PubMed ID: 36047381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances.
    Fass JA; Hardigan PC
    J Manag Care Pharm; 2011; 17(6):430-8. PubMed ID: 21787028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the Theory of Planned Behavior to assess community pharmacists' intention to prescribe using the Formulary and Protocol Compendia.
    Wash A; Moczygemba LR; Anderson L; Pye T
    Res Social Adm Pharm; 2022 Dec; 18(12):4056-4064. PubMed ID: 35864036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Readiness of Pharmacists Based in Utah About Pain Management and Opioid Dispensing.
    Balough MM; Nwankpa S; Unni EJ
    Pharmacy (Basel); 2019 Jan; 7(1):. PubMed ID: 30650559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation and assessment of a naloxone-training program for first-year student pharmacists.
    Schartel A; Lardieri A; Mattingly A; Feemster AA
    Curr Pharm Teach Learn; 2018 Jun; 10(6):717-722. PubMed ID: 30025771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.